Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Dose Received by the Prostate With in Vivo Dosimetry in Patients Treated With Daily IGRT Associated With IMRT Using Two Repositioning Techniques for Localized Prostate Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* male \> 18 years~* carcinoma of the prostate histologically confirmed~* OMS 0-1~* localized stage~* favorable, intermediate and unfavorable groups according to NCCN or D'Amico classification~* patients must have signed a written informed consent form~* patients must be affiliated to a Social Health Insurance.~Exclusion Criteria:~* metastasis~* indication for pelvic radiation~* anticoagulant therapy~* lateral or bilateral hip replacement~* patient receiving an adult protective services~* Patient unable to comply with the required medical follow-up for geographic, social or psychological reasons

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- CBCT (Type: OTHER): cone beam computed tomography (CBCT) repositioning
- fiducial markers (Type: OTHER): kV imaging of fiducial marker repositioning

Based on this trial design, predict the completion outcome and termination type (if applicable).